Aignostics announces a partnership with the Pancreatic Cancer Action Network (PanCAN) aimed at advancing pancreatic cancer research. The collaboration applies Aignostics’ AI technology to PanCAN’s multimodal dataset on pancreatic cancer. The outlets describe the dataset as comprising multiple data types, and the work focuses on using Aignostics’ tools to analyze or derive results from that information. A key element highlighted across the sources is broad accessibility: results from the partnership are intended to be made widely available to researchers, including academic and life sciences teams. The announcements present the partnership as a step toward accelerating research efforts by combining Aignostics’ artificial intelligence capabilities with PanCAN’s data resources. The press materials are issued from multiple locations (Los Angeles, Berlin, and New York) and date the announcement to June 9, 2026. Overall, the coverage emphasizes the AI-plus-dataset collaboration and the plan to share outputs with the wider research community rather than focusing on specific scientific findings at the time of announcement.